93 related articles for article (PubMed ID: 25854421)
1. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):640-7. PubMed ID: 25854421
[TBL] [Abstract][Full Text] [Related]
2. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
[TBL] [Abstract][Full Text] [Related]
4. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
6. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
[TBL] [Abstract][Full Text] [Related]
8. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
[TBL] [Abstract][Full Text] [Related]
9. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
[TBL] [Abstract][Full Text] [Related]
10. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
11. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
12. Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.
Villalón CM; Centurión D; Luján-Estrada M; Terrón JA; Sánchez-López A
Br J Pharmacol; 1997 Apr; 120(7):1319-27. PubMed ID: 9105708
[TBL] [Abstract][Full Text] [Related]
13. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation.
Morán A; Velasco C; Martín ML; San Román L
Eur J Pharmacol; 1997 Jul; 330(2-3):205-11. PubMed ID: 9253955
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxytryptamine-induced vasodilator responses in the hindquarters of the anaesthetized rat, involve beta2-adrenoceptors.
Calama E; García M; Jarque MJ; Morán A; Martín ML; San Román L
J Pharm Pharmacol; 2003 Oct; 55(10):1371-8. PubMed ID: 14607019
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
16. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT
Fernández-González JF; García-Pedraza JÁ; Ordóñez JL; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674892
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine oral treatment discloses 5-HT
López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
[TBL] [Abstract][Full Text] [Related]
19. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
[TBL] [Abstract][Full Text] [Related]
20. Vasoconstrictor and vasodilator effects of serotonin in the isolated rabbit kidney.
Li T; Croce K; Winquist RJ
J Pharmacol Exp Ther; 1992 Dec; 263(3):928-32. PubMed ID: 1469648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]